News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
484,340 Results
Type
Article (8036)
Company Profile (140)
Press Release (476259)
Multimedia
Podcasts (4)
Webinars (6)
Section
Business (166745)
Career Advice (305)
Deals (25738)
Drug Delivery (7)
Drug Development (52877)
Employer Resources (14)
FDA (9763)
Job Trends (8574)
News (238195)
Policy (17906)
Tag
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (4)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (486)
Accelerated approval (24)
ADA (18)
Adcomms (1)
Allergies (96)
Alliances (33154)
ALS (104)
Alzheimer's disease (973)
Antibody-drug conjugate (ADC) (262)
Approvals (10370)
Artificial intelligence (319)
ASCO (159)
Autoimmune disease (205)
Automation (28)
Bankruptcy (262)
Best Places to Work (6958)
BIO (36)
BIOSECURE Act (1)
Biosimilars (108)
BioSpace Insights (17)
Biotechnology (88)
Bladder cancer (138)
Brain cancer (28)
Breast cancer (506)
Cancer (3627)
Cardiovascular disease (217)
Career advice (245)
Career pathing (1)
CAR-T (172)
Celiac Disease (1)
Cell therapy (476)
Cervical cancer (34)
Clinical research (47844)
Collaboration (1238)
Commercialization (3)
Compensation (1445)
Complete response letters (34)
COVID-19 (754)
CRISPR (63)
C-suite (736)
Cystic fibrosis (85)
Data (5611)
Denatured (4)
Depression (102)
Dermatology (60)
Diabetes (341)
Diagnostics (4177)
Digital health (37)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (154)
Drug pricing (7)
Drug shortages (2)
Duchenne muscular dystrophy (163)
Earnings (73603)
Editorial (1)
Employer branding (2)
Employer resources (14)
Events (87579)
Executive appointments (697)
FDA (12367)
Fibrodysplasia Ossificans Progressiva (8)
Friedreich's ataxia (18)
Frontotemporal dementia (23)
Funding (908)
Gene editing (125)
Generative AI (9)
Gene therapy (315)
GLP-1 (289)
Government (941)
Grass and pollen (2)
Guidances (281)
Healthcare (9313)
Hematology (94)
HIV (52)
Huntington's disease (22)
IgA nephropathy (64)
Immunology and inflammation (98)
Immuno-oncology (56)
Indications (155)
Infectious disease (942)
Inflammatory bowel disease (126)
Inflation Reduction Act (4)
Influenza (84)
Intellectual property (253)
Interviews (41)
IPO (12386)
IRA (2)
Job creations (1968)
Job search strategy (235)
JPM (1)
Kidney cancer (16)
Layoffs (59)
Legal (5195)
Licensing (7)
Liver cancer (44)
Longevity (15)
Lung cancer (505)
Lymphoma (249)
Machine learning (27)
Management (3)
Manufacturing (527)
Marketing (8)
MASH (118)
Medical device (8650)
Medtech (8790)
Mergers & acquisitions (14377)
Metabolic disorders (704)
mRNA (53)
Multiple sclerosis (102)
NASH (4)
Neurodegenerative disease (220)
Neuropsychiatric disorders (38)
Neuroscience (1816)
NextGen: Class of 2026 (3150)
Non-profit (841)
Obesity (223)
Opinion (10)
Ovarian cancer (158)
Pain (170)
Pancreatic cancer (195)
Parkinson's disease (201)
Partnered (12)
Patents (472)
Patient recruitment (502)
Peanut (31)
People (41206)
Pharmaceutical (30)
Pharmacy benefit managers (8)
Phase 1 (15458)
Phase 2 (21368)
Phase 3 (14388)
Pipeline (7171)
Policy (18)
Postmarket research (1570)
Preclinical (6536)
Press Release (34)
Prostate cancer (189)
Psychedelics (7)
Radiopharmaceuticals (189)
Rare diseases (569)
Real estate (3019)
Recruiting (6)
Regulatory (14786)
Reports (19)
Research institute (581)
Resumes & cover letters (45)
Rett syndrome (41)
RNA editing (5)
RSV (48)
Schizophrenia (99)
Series A (152)
Series B (121)
Service/supplier (5)
Sickle cell disease (62)
Spinal muscular atrophy (88)
Sponsored (5)
Startups (2018)
Stomach cancer (3)
Supply chain (50)
Vaccines (317)
Venture capital (17)
Weight loss (73)
Women's health (78)
Date
Today (71)
Last 7 days (443)
Last 30 days (1620)
Last 365 days (19113)
2026 (11965)
2025 (19251)
2024 (22986)
2023 (26541)
2022 (34587)
2021 (37167)
2020 (33470)
2019 (23256)
2018 (17501)
2017 (18769)
2016 (17917)
2015 (24268)
2014 (21683)
2013 (18135)
2012 (20221)
2011 (20440)
2010 (20333)
Location
Africa (228)
Alabama (72)
Alaska (2)
Arizona (300)
Arkansas (11)
Asia (17882)
Australia (2097)
California (11868)
Canada (3118)
China (517)
Colorado (479)
Connecticut (406)
Delaware (207)
Europe (24619)
Florida (1774)
Georgia (373)
Hawaii (3)
Idaho (46)
Illinois (695)
India (48)
Indiana (314)
Iowa (14)
Japan (398)
Kansas (100)
Kentucky (30)
Louisiana (26)
Maine (26)
Maryland (1189)
Massachusetts (7812)
Michigan (307)
Minnesota (558)
Mississippi (4)
Missouri (80)
Montana (20)
Nebraska (11)
Nevada (114)
New Hampshire (60)
New Jersey (2604)
New Mexico (12)
New York (2803)
North Carolina (1264)
North Dakota (4)
Northern California (5941)
Ohio (276)
Oklahoma (14)
Oregon (18)
Pennsylvania (2242)
Puerto Rico (20)
Rhode Island (30)
South America (406)
South Carolina (76)
South Dakota (1)
Southern California (4924)
Tennessee (119)
Texas (1915)
United States (38578)
Utah (357)
Vermont (1)
Virginia (153)
Washington D.C. (38)
Washington State (919)
West Virginia (1)
Wisconsin (73)
484,340 Results for "synedgen inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Beach
Synedgen Completes IND-Enabling Studies for Two Parallel Programs for Lead Asset MIIST305
Synedgen, Inc. announced it has completed IND-enabling studies for its lead candidate, MIIST305.
April 25, 2024
·
4 min read
Press Releases
Synedgen Promotes Dr. Laura Saward to Chief Executive Officer and Appoints Dr. Kenton Gregory to Chief Medical Officer
July 3, 2025
·
4 min read
Press Releases
Synedgen Announces Appointment of Dr. Laura Saward as Chief Scientific Officer
February 11, 2025
·
3 min read
Press Releases
Synedgen Adds Dr. Hal J. Oien to its Board of Directors
September 24, 2024
·
2 min read
Press Releases
Synedgen Announces Gut Microbes Publication of Preclinical Data Showing MIIST305 Mitigates Gastrointestinal Acute Radiation Syndrome Injury in a Murine Model
February 26, 2025
·
3 min read
Press Releases
Synedgen Announces $2.2 Million JWMRP Award for MIIST305 For Use as a Prophylactic Radiation Medical Countermeasure
November 1, 2024
·
4 min read
Press Releases
Synedgen Receives Contract from BARDA to Develop MIIST305 as a Medical Countermeasure for Gastrointestinal Acute Radiation Syndrome
October 15, 2024
·
4 min read
Business
Synedgen Appoints Industry Veteran Dennis Fenton, Ph.D., to Board of Directors
Synedgen, a biopharma company dedicated to using its Multivalent Innate Immune Signaling Target (MIIST) platform to develop drugs that mimic and enhance the innate immune system, today announced that industry veteran Dennis Fenton, Ph.D., has joined Synedgen’s Board of Directors.
February 18, 2021
·
2 min read
Biotech Beach
Synedgen Partnership with the University of New South Wales Receives Australian Research Council (ARC) Grant
Synedgen’s CEO, Shenda Baker, gave a related keynote lecture at the Pan Pacific Connective Tissue Societies Symposium on November 25, 2020
December 10, 2020
·
3 min read
Press Releases
Tevogen Bio Holdings Inc. Becomes Tevogen Inc.
July 29, 2026
·
4 min read
1 of 48,434
Next
